Download Full Text PDF - Jaypee Journals

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Gastroenteritis wikipedia , lookup

Skin flora wikipedia , lookup

Antimicrobial surface wikipedia , lookup

Neonatal infection wikipedia , lookup

Metagenomics wikipedia , lookup

Urinary tract infection wikipedia , lookup

Community fingerprinting wikipedia , lookup

Horizontal gene transfer wikipedia , lookup

Bacteria wikipedia , lookup

Infection control wikipedia , lookup

Infection wikipedia , lookup

Esther Lederberg wikipedia , lookup

Magnetotactic bacteria wikipedia , lookup

Virology wikipedia , lookup

Anaerobic infection wikipedia , lookup

Traveler's diarrhea wikipedia , lookup

Bacterial cell structure wikipedia , lookup

Carbapenem-resistant enterobacteriaceae wikipedia , lookup

Human microbiota wikipedia , lookup

Disinfectant wikipedia , lookup

Triclocarban wikipedia , lookup

History of virology wikipedia , lookup

Marine microorganism wikipedia , lookup

Hospital-acquired infection wikipedia , lookup

Bacterial morphological plasticity wikipedia , lookup

Transcript
10.5005/jp-journals-10011-1337
Hema Gopalaiah
REVIEW ARTICLE
Bacteriophage as Antimicrobial Agents: A Milestone
Hema Gopalaiah
ABSTRACT
Bacteriophages are the viruses with either DNA or RNA as the
genetic material.1 Phages have a developmental cycle within
the host bacteria which can be lytic or lysogenic. The lytic cycle
comprises has a series of events that subsequenty release
daughter phage particles. Phage for a given bacterium can be
isolated wherever that bacterium grows.2 The problem is not
just isolating the phage against particular bacteria but in selecting
the ones most likely to be useful for clinical application.
Keywords: Lytic cycle, Bacterial genome, Phage therapy.
How to cite this article: Gopalaiah H. Bacteriophage as
Antimicrobial Agents: A Milestone. J Indian Acad Oral Med Radiol
2013;25(1):40-41.
Source of support: Nil
Conflict of interest: None declared
INTRODUCTION
Bacteriophages were discovered in 1951 by Towart.3 He
described degenerative changes present in staphylococcal
colonies isolated from calf lymph, which could be
transmitted serially by application of culture filtrates from
the original growth. Bacteriophages are the viruses with
either DNA or RNA as the genetic material and both singleand double-stranded forms of each are known. Phages have
a developmental cycle within the host bacteria which can
be lytic or lysogenic. The lytic cycle comprises a series of
events that occur between attachment of phage particle to
a bacterial cell and its subsequent release of daughter
phage particles.
Phage for a given bacterium can be isolated wherever
that bacterium grows, such as in feces, sewage, soil, hot
springs oceans. Water from the Ganges (India) has been
found to be a rich source of vibrio phages. The problem is
not isolating phage against particular bacteria but in
selecting the ones most likely to be useful for clinical
purposes.4
surrounded by a protein coat or capsid. The size of the head
varies in different phages from 28 to 100 nm. The tail is
composed of a hollow core, and terminal base plate which
has attached to it prongs, tail fibers or both.
Though most bacteriophages have the morphology and
structure described above, phages have been identified that
are spherical or filamentous and possess single stranded
DNA or RNA.
LIFE CYCLE
Phages exhibit two different types of life cycle. In the
virulent or lytic cycle, intracellular multiplication of the
phage culminates in the lysis of the host bacterium and the
release of progeny virus. In the temperate or lysogenic cycle
the phage DNA becomes integrated with the bacterial
genome, replicating synchronously with it, causing no harm
to the host cell.
REVIEWS
Cislo et al studied the effect of concomitant topical and
oral phage therapy on infected skin ulcers in 31 patients.
There was marked improvement in 74.2% (23/31) patients
which in seven patients the study could not be conducted
due to side effects of phage therapy in the form of either
eczema or pain or vomiting.5
In 1974, studies were conducted in Tbilisi Georgia, by
Sakandelidze et al who treated patients of antibiotic resistant
osteomyelitis. Lung abscess, peritonitis and postsurgical
wound infections with pyohage which is mixture of phage
active against Staphylococcus, proteus and Streptococcus
or diphage (Staphylococcus and proteus phages). Phage
was applied subcutaneously or via the surgical drain
daily for 5 to 10 days and improvement was seen in 92% of
these cases.6
MORPHOLOGY
Certain bacteriophages that infect E. coli, called the T even
phages (T2, T4, T6), have been studied in great detail and
traditionally serve as the prototypes in describing the
properties of bacteriophages.
T even phages have a complex and characteristic
morphology (Fig. 1). They are tadpole shaped, with a
hexagonal head and a cylindrical tail. The head consists of
a tightly packed core of nucleic acid (double-stranded DNA)
40
Fig. 1: Bacteriophage
JIAOMR
Bacteriophage as Antimicrobial Agents: A Milestone
Weber et al in 1987 assessed the extent to which orally
administered antistaphylococcal and antipseudomonal
phage penetrated into the serum or urine of 56 patients with
suppurative bacterial infection. By 10th day of therapy, it
was found that 84% serum samples and 35% urine samples
contained phage indicating a high bioavailablility.6
In 1989 Kochetkova et al conducted a detailed and
quantitative study in 131 cancer patients suffering
postoperative would infections. Phages produced positive
clinical results in 81.5% of patients. Phage therapy was
found to be more effective for cutaneous would infections
by local application than for pleural empyema, mediastinitis
or osteomyelitis. Antipseudomonal phages were found to
be most effective (86.7%) followed by staphylococcal
(74.7%) phages.6
CONCLUSION
CLINICAL IMPLICATIONS
REFERENCES
Phages have specific properties which give them advantages
as therapeutic agents. They are self-replicating as well as
self-limiting. They continue to multiply and penetrate deeper
as long as local infection is present. This is sharp contrast
to antibiotics which decrease in concentration below the
site of infection. Phages are lytic against specific bacteria
so they can be targeted more specifically than antibiotics
which are active against a group of bacteria. Phages do not
harm normal intestinal microflora.7 Antibiotics have side
effects which can be serious. But phages have been used in
millions of patients without any reported side effects. Phages
can be used prophylactically as well as in established
infections. The self-perpetuating nature of phages in the
presence of susceptible bacteria makes multiple
administrations8,9 unnecessary. It also allows transfer of
administered phages between animals in a farmyard.9,10
DISADVANTAGES
Problems faced in phages studies were poor understanding
of heterogeneity and ecology of both the phages and the
bacteria. Involved there was also difficulty in selecting
appropriate mixture of phages of high virulence against the
target bacteria. Failure to correctly and appropriately
characterize the phage proportions was another reason for
hampering the progress of these studies. Phages with high
activity in vitro are more active in vivo.9 Maintenance of
phages by regular propagation needs expertise and an
established setup.
Bacteriophages are bacterial vs that invade bacterial cells
and are among the most abundant lining entities on earth
playing important roles in maintaining the natural abundance
and distribution of microorganisms. Phage therapy for
eliminating multidrug resistant bacteria is gaining
importance. There is need to carry out further studies on
phages as therapeutic agents using specific phage stains
against the corresponding bacterial hosts.
Use of antibiotics along with phages has been tried with
limited benefit because antibiotics are more likely to inhibit
phage effectiveness than to enhance it and combination may
result in problem/resistant genes. Hence, it is concluded that
phage therapy alone is more effective.
1. Bennett PM, Howe TGB. Bacterial and bacteriophage genetics.
In: Collier L, Balows A, Sussman M, editors. Topley and
Wilson’s microbiology and microbial infections. 9th ed. London:
Arnold Publishers 1998;2:231-286.
2. Topley WWC, Wilson GS. The principles of bacteriology and
immunity. New York: William Wood and Company 1929;1:
224-233.
3. Adams MH. Bacteriophages. New York: Interscience Publishers
Inc 1959:1-2.
4. Brock TD. Milestones in microbiology. Washington DC:
American Society of Microbiology 1961:1:157-159.
5. Alisky J, lczkowski K, Rapoport A, Troitsky N. Bacteriophages
show promise as antimicrobial agents. J Infect 1989;36:5-15.
6. Nakai T, Park SC. Bacteriophage therapy of infectious disease
in aquaculture. Res Microbiol 2002:153:13-18.
7. Barrow PA, Soothill JS. Bacteriophage therapy and prophylaxis:
rediscovery and renewed assessment of potential. Trends
Microbiol 1997;5:268-271.
8. Smith HW, Huggins MB. Successful treatment of experimental
Escherichia coli infections in mice using phage: its general
superiority over antibiotic. J Gen Microbial 1982;128:307-318.
9. Berchieri A Jr, Lovell MA, Barrow PA. The activity in the
chicken alimentary tract of bacteriophages lytic for Salmonella
typhimurium. Res Microbial 1991;142:541-549.
10. Ananthanarayan R, Peniker CKJ. Textbook of microbiology,
6th edition. Orient Longman 2003.p.431-434.
ABOUT THE AUTHOR
Hema Gopalaiah
Reader, Department of Oral Medicine and Radiology, Sri Mookambika
Institute of Dental Science, Kanyakumari, Tamil Nadu, India, e-mail:
[email protected]
Journal of Indian Academy of Oral Medicine and Radiology, January-March 2013;25(1):40-41
41